Pharmacophore Modelling: Methods,Experimental Verification and Applications

[1]  Stephen D. Pickett,et al.  Diversity Profiling and Design Using 3D Pharmacophores: Pharmacophore-Derived Queries (PDQ) , 1996, J. Chem. Inf. Comput. Sci..

[2]  Anton J. Hopfinger,et al.  Conformational Analysis, Molecular Shape Comparison, and Pharmacophore Identification of Different Allosteric Modulators of Muscarinic Receptors , 1996, J. Chem. Inf. Comput. Sci..

[3]  Regine Bohacek,et al.  Three-Dimensional Models of ACE and NEP Inhibitors and Their Use in the Design of Potent Dual ACE/NEP Inhibitors , 1996 .

[4]  Vithal M. Kulkarni,et al.  A proposed common spatial pharmacophore and the corresponding active conformations of some peptide leukotriene receptor antagonists , 1996, J. Comput. Aided Mol. Des..

[5]  André Michel,et al.  Solution conformation by NMR and molecular modeling of three sulfide-free somatostatin octapeptide analogs compared to angiopeptin , 1996, J. Comput. Aided Mol. Des..

[6]  Gareth Jones,et al.  A genetic algorithm for flexible molecular overlay and pharmacophore elucidation , 1995, J. Comput. Aided Mol. Des..

[7]  E. Novellino,et al.  A concerted study using binding measurements, X-ray structural data, and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines toward mitochondrial benzodiazepine receptors. , 1995, Journal of medicinal chemistry.

[8]  A. Dolmella,et al.  X-ray studies, empirical, semi-empirical and statistical calculations on a series of thyrotropin-releasing hormone derivatives , 1995 .

[9]  D. Boger,et al.  N-Desmethyl Derivatives of Deoxybouvardin and RA-VII: Synthesis and Evaluation , 1995 .

[10]  V. Cody,et al.  Conformational Analysis of Methylphenidate and Its Structural Relationship to Other Dopamine Reuptake Blockers Such as CFT , 1995, Pharmaceutical Research.

[11]  Motoo Shiro,et al.  Conformational analysis of a cyclic hexapeptide, segetalin A from Vaccaria segetalis , 1995 .

[12]  A. Ghose,et al.  Determination of Pharmacophoric Geometry for Collagenase Inhibitors Using a Novel Computational Method and Its Verification Using Molecular Dynamics, NMR, and X-ray Crystallography , 1995 .

[13]  M C Nicklaus,et al.  Conformational changes of small molecules binding to proteins. , 1995, Bioorganic & medicinal chemistry.

[14]  M. Reily,et al.  Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues. , 1995, Journal of Medicinal Chemistry.

[15]  N. Cohen,et al.  The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses. , 1993, Journal of medicinal chemistry.

[16]  Edward P. Jaeger,et al.  The use of an algorithmic method for small molecule superimpositions in the design of antiviral agents , 1993, J. Comput. Aided Mol. Des..

[17]  R C Glen,et al.  Molecular recognition using a binary genetic search algorithm. , 1993, Journal of molecular graphics.

[18]  Yvonne C. Martin,et al.  A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists , 1993, J. Comput. Aided Mol. Des..

[19]  P Willett,et al.  Pharmacophoric pattern matching in files of three-dimensional chemical structures: use of smoothed bounded distances for incompletely specified query patterns. , 1991, Journal of molecular graphics.

[20]  Arup K. Ghose,et al.  Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics , 1989, J. Chem. Inf. Comput. Sci..

[21]  G M Crippen,et al.  Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure. , 1989, Journal of medicinal chemistry.

[22]  Brian W. Matthews,et al.  Structural basis of the action of thermolysin and related zinc peptidases , 1988 .

[23]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[24]  R. Sheridan,et al.  The ensemble approach to distance geometry: application to the nicotinic pharmacophore. , 1986, Journal of medicinal chemistry.

[25]  A. Ghose,et al.  Geometrically feasible binding modes of a flexible ligand molecule at the receptor site , 1985 .

[26]  A. Ghose,et al.  Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors. , 1985, Journal of medicinal chemistry.

[27]  G M Crippen,et al.  General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors. , 1984, Journal of medicinal chemistry.

[28]  D. K. Friesen,et al.  A combinatorial algorithm for calculating ligand binding , 1984 .

[29]  G M Crippen,et al.  Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reductase inhibitors. , 1980, Journal of medicinal chemistry.

[30]  Garland R. Marshall,et al.  The Conformational Parameter in Drug Design: The Active Analog Approach , 1979 .

[31]  G M Crippen,et al.  Distance geometry approach to rationalizing binding data. , 1979, Journal of medicinal chemistry.

[32]  Gordon M. Crippen,et al.  Stable calculation of coordinates from distance information , 1978 .

[33]  Hans-Dieter Höltje,et al.  24 – PHARMACOPHORE IDENTIFICATION AND RECEPTOR MAPPING , 2003 .

[34]  Hugo Kubinyi,et al.  3D QSAR in drug design : theory, methods and applications , 2000 .

[35]  U. Holzgrabe,et al.  Search for the Pharmacophore in Kappa‐agonistic Diazabicyclo[3.3.1]nonan‐9‐one‐1,5‐diesters and Arylacetamides , 1996, Archiv der Pharmazie.

[36]  H. V. Van Wart,et al.  Synthetic inhibitors of bacterial and mammalian interstitial collagenases. , 1992, Progress in medicinal chemistry.

[37]  N. Vermeulen,et al.  Comprehensive medicinal chemistry , 1991 .

[38]  Edwin F. Hilinski,et al.  Mathematical and computational concepts in chemistry : Edited by Nenad Trinajsti, Ellis Horwood, Chichester, 1986. ISBN 0-85312-934-7, 365 pages plus index , 1987, Comput. Chem..

[39]  N. Borkakoti,et al.  Collagenase inhibitors: their design and potential therapeutic use. , 1987, Journal of enzyme inhibition.

[40]  Mary Ann Moran,et al.  Synthesis and Evaluation , 1986 .

[41]  Peter Gund,et al.  Chapter 29 Pharmacophoric Pattern Searching and Receptor Mapping , 1979 .

[42]  P. Ehrlich.  Über den jetzigen Stand der Chemotherapie , 1909 .